Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pimicotinib |
| Trade Name | Pimjetmi |
| Synonyms | ABSK 021|ABSK-021|CSF-1R Inhibitor ABSK021|ABSK021 |
| Drug Descriptions |
Pimjetmi (pimicotinib) selectively inhibits CSF1R, potentially leading to inhibition of tumor cell proliferation, enhanced T cell immune response, and antitumor activity (J Clin Oncol 41, 2023 (suppl 16; abstr 11559, PMID: 41796601). Pimjetmi (pimicotinib) is FDA-approved for use in patients with symptomatic tenosynovial giant cell tumor (FDA.gov). |
| DrugClasses | CSF1R Inhibitor 28 |
| CAS Registry Number | 2253123-16-7 |
| NCIT ID | C173651 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pimicotinib | Pimicotinib | 0 | 3 |